Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report

J Dermatolog Treat. 2024 Dec;35(1):2319303. doi: 10.1080/09546634.2024.2319303. Epub 2024 Feb 20.

Authors

Mario Valenti^{1

2}, Luigi Gargiulo^{1

2}, Luciano Ibba^{1

2}, Alexia Bertuzzi³, Sofia Manara⁴, Francesco Toso^{1

2}, Antonio Costanzo^{1

2}, Alessandra Narcisi²

Affiliations

¹ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
² Dermatology Unit, Humanitas Research Hospital IRCCS, Rozzano, Italy.
³ Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Italy.
⁴ Pathology Unit, Humanitas Research Hospital IRCCS, Rozzano, Italy.

PMID: 38378173
DOI: 10.1080/09546634.2024.2319303

No abstract available

Publication types

Case Reports

MeSH terms

Etoposide / therapeutic use
Humans
Ifosfamide / therapeutic use
Neoadjuvant Therapy
Psoriasis* / drug therapy
Sarcoma, Ewing* / drug therapy
Thalidomide / analogs & derivatives*

Substances

Etoposide
Ifosfamide
apremilast
Thalidomide